Quest Diagnostics unveiled a new artificial intelligence-based test service in the U.S. that aims to help physicians improve the detection of dementia and create better outcomes for patients. Through ...

In September 2024, Quest Diagnostics was awarded several contracts by the U.S. Centers for Disease Control and Prevention (CDC) to support testing and sustained laboratory readiness for emerging ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics (NYSE:DGX) announced a US$500 million senior notes offering. The company also entered a multi year clinical partnership with City of Hope focused on advanced ctDNA testing. The ...

Quest Diagnostics has announced that it will now offer consumer-initiated laboratory testing powered by QuestDirect in collaboration with Walmart. The new solution allows people to take control of ...

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ -- Quest Diagnostics (DGX), a ...

GRAIL’s Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif. and ...

Quest Diagnostics delivered first quarter results that exceeded Wall Street’s revenue and profit expectations, driven by ...

April 21 (Reuters) - Quest Diagnostics on Tuesday raised its forecast for 2026 profit and revenue after posting first-quarter results above Wall Street estimates, citing resilient demand for routine ...

Quest Diagnostics Incorporated DGX recently announced that the company is now offering the liquid biopsy-based Target Selector NGS Lung Panel test developed by Biocept BIOC. The addition of this blood ...

Quest Diagnostics Incorporated DGX recently entered into a collaboration with CLX Health to offer access to COVID-19 molecular diagnostic testing (PCR/NAAT) for people looking to attend live events ...

Though demand for COVID-19 testing this year has receded faster than many diagnostics companies expected, the quick return of patients to the clinic for routine care—such as screenings for heart ...